Cargando…
Surgical Treatment of Trichilemmal Carcinoma
BACKGROUND: To investigate the clinicopathologic characteristics and prognostic factors of trichilemmal carcinoma (TC), and to determine an optimal treatment strategy for these patients. METHODS: This retrospective study enrolled consecutive patients who were admitted to the Sun Yat-sen University C...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279458/ https://www.ncbi.nlm.nih.gov/pubmed/30524638 http://dx.doi.org/10.14740/wjon1143w |
_version_ | 1783378506668834816 |
---|---|
author | Xu, De Bin Wang, Tao Liao, Zhen |
author_facet | Xu, De Bin Wang, Tao Liao, Zhen |
author_sort | Xu, De Bin |
collection | PubMed |
description | BACKGROUND: To investigate the clinicopathologic characteristics and prognostic factors of trichilemmal carcinoma (TC), and to determine an optimal treatment strategy for these patients. METHODS: This retrospective study enrolled consecutive patients who were admitted to the Sun Yat-sen University Cancer Center between 1998 and 2012. RESULTS: The key prognostic factors influencing the survival were lymph nodes metastasis and surgery margin. Multivariate analysis revealed that there was no risk factor for patient survival. CONCLUSIONS: Surgery margin and lymph nodes metastasis were prognostic factors that influenced the treatment outcome. Simple excision with 1 cm margins is safe, inexpensive and effective for the treatment of TC; and postoperative follow-up of the patient to facilitate early diagnosis of the recurrence and distant metastasis is necessary. Systemic chemotherapy should be considered for the distance metastases patients. |
format | Online Article Text |
id | pubmed-6279458 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elmer Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62794582018-12-06 Surgical Treatment of Trichilemmal Carcinoma Xu, De Bin Wang, Tao Liao, Zhen World J Oncol Original Article BACKGROUND: To investigate the clinicopathologic characteristics and prognostic factors of trichilemmal carcinoma (TC), and to determine an optimal treatment strategy for these patients. METHODS: This retrospective study enrolled consecutive patients who were admitted to the Sun Yat-sen University Cancer Center between 1998 and 2012. RESULTS: The key prognostic factors influencing the survival were lymph nodes metastasis and surgery margin. Multivariate analysis revealed that there was no risk factor for patient survival. CONCLUSIONS: Surgery margin and lymph nodes metastasis were prognostic factors that influenced the treatment outcome. Simple excision with 1 cm margins is safe, inexpensive and effective for the treatment of TC; and postoperative follow-up of the patient to facilitate early diagnosis of the recurrence and distant metastasis is necessary. Systemic chemotherapy should be considered for the distance metastases patients. Elmer Press 2018-11 2018-11-23 /pmc/articles/PMC6279458/ /pubmed/30524638 http://dx.doi.org/10.14740/wjon1143w Text en Copyright 2018, Xu et al. http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Xu, De Bin Wang, Tao Liao, Zhen Surgical Treatment of Trichilemmal Carcinoma |
title | Surgical Treatment of Trichilemmal Carcinoma |
title_full | Surgical Treatment of Trichilemmal Carcinoma |
title_fullStr | Surgical Treatment of Trichilemmal Carcinoma |
title_full_unstemmed | Surgical Treatment of Trichilemmal Carcinoma |
title_short | Surgical Treatment of Trichilemmal Carcinoma |
title_sort | surgical treatment of trichilemmal carcinoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279458/ https://www.ncbi.nlm.nih.gov/pubmed/30524638 http://dx.doi.org/10.14740/wjon1143w |
work_keys_str_mv | AT xudebin surgicaltreatmentoftrichilemmalcarcinoma AT wangtao surgicaltreatmentoftrichilemmalcarcinoma AT liaozhen surgicaltreatmentoftrichilemmalcarcinoma |